Literature DB >> 9267985

Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat.

G M Pieper1, W Siebeneich, G Moore-Hilton, A M Roza.   

Abstract

We examined the effects of acute supplementation with arginine in vitro on endothelium-dependent relaxation in aortic rings taken from female genetic, diabetes-prone BB rats. Sensitivity to norepinephrine-induced contraction was unaltered in rings of diabetic BB rats compared to rings from non-diabetic littermates. In precontracted rings, acetylcholine produced a concentration-dependent relaxation which was impaired by diabetes. This relaxation was blocked by L-nitroarginine in both control and diabetic rings. Addition of 3 mmol/l L-arginine (but not D-arginine) enhanced relaxation in diabetic rings similar to that seen in control rings without arginine. L-arginine had no effect on acetylcholine-induced relaxation in control rings. In contrast, relaxation-induced by nitroglycerin in diabetic rings without endothelium was not altered by L-arginine treatment. Thus, a defect in the utilization of arginine by nitric oxide synthase exists in the endothelium of the diabetic BB rat.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267985     DOI: 10.1007/s001250050767

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Shota Kobayashi; Takayuki Matsumoto; Makoto Ando; Maika Iguchi; Shun Watanabe; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2017-11-29       Impact factor: 3.765

2.  Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Yoshihiro Kuno; Masayuki Iyoda; Takanori Shibata; Yuki Hirai; Tadao Akizawa
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  Oxidative stress, nitric oxide, and diabetes.

Authors:  Dario Pitocco; Francesco Zaccardi; Enrico Di Stasio; Federica Romitelli; Stefano A Santini; Cecilia Zuppi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2010-05-10

4.  Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.

Authors:  Timea Beleznai; Attila Feher; David Spielvogel; Steven L Lansman; Zsolt Bagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-07       Impact factor: 4.733

5.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 6.  Endothelial nitric oxide (NO) and its pathophysiologic regulation.

Authors:  Anuran Chatterjee; Stephen M Black; John D Catravas
Journal:  Vascul Pharmacol       Date:  2008-07-20       Impact factor: 5.773

7.  Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine.

Authors:  A Georgescu; D Popov
Journal:  J Am Aging Assoc       Date:  2000-01

8.  Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.

Authors:  Tarunveer Singh Ahluwalia; Monica Ahuja; Taranjit Singh Rai; Harbir Singh Kohli; Kamal Sud; Anil Bhansali; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2008-04-10       Impact factor: 3.396

9.  Effects of glucose tolerance on the changes provoked by glucose ingestion in microvascular function.

Authors:  A Natali; S Baldi; F Vittone; E Muscelli; A Casolaro; C Morgantini; C Palombo; E Ferrannini
Journal:  Diabetologia       Date:  2008-03-29       Impact factor: 10.122

10.  Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS.

Authors:  Mark J Crabtree; Caroline L Smith; George Lam; Michael S Goligorsky; Steven S Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.